TRexBio Prices $116.7 Million Initial Public Offering

MT newswire2026/10/09 08:10

04:10 AM EDT, 10/09/2026 (MT Newswires) -- TRexBio (TRXB) said Thursday it priced its initial public offering of roughly 8.3 million common shares at $14 per share. The company expects to raise roughly $116.7 million in gross proceeds from the sale, and its stock is expected to begin trading Friday on the Nasdaq Global Select Market (NDAQ) under the ticker symbol TRXB, the company said. Underwriters have a 30-day option to buy up to an additional 1.25 million shares, and the transaction is expected to close Oct. 13, pending customary conditions, TRexBio said.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

UK funds significantly reduced their holdings in SpaceX last week and had fully exited Tesla as of April.

格隆汇•2026/11/09 05:55

Swiss Franc weakens as Fed hawkish outlook lifts USD/CHF

FXStreet•2026/11/09 05:45

Sun Machinery CEO Park Kyung-hee Raises Stake to 8.40% From 8.31%

Bitget•2026/11/09 05:37

The central bank has increased its gold reserves for 24 consecutive months, with October’s increase hitting a record high for the period.

新浪财经•2026/11/09 05:37